Peter James Krause, MD

• Adeel Zubair
• Choukri Ben Mamoun
• Erol Fikrig
• Eugene Shapiro
• Linda Bockenstedt
• Linda Niccolai
• Shaili Gupta
• Shelli Farhadian
• Sukanya Narasimhan

Babesiosis; Blood Transfusion; Epidemiology; Lyme Disease; Relapsing Fever; Borrelia burgdorferi; Infectious Disease Medicine; Biostatistics; Diseases

Infectious Diseases; Vector-borne Diseases; Tick-borne Diseases

• Transfusion-transmitted Babesia spp.: a changing landscape of epidemiology, regulation, and risk mitigationDrews S, Kjemtrup A, Krause P, Lambert G, Leiby D, Lewin A, O'Brien S, Renaud C, Tonnetti L, Bloch E. Transfusion-transmitted Babesia spp.: a changing landscape of epidemiology, regulation, and risk mitigation. Journal Of Clinical Microbiology 2023, 61: e01268-22. PMID: 37750699, PMCID: PMC10595070, DOI: 10.1128/jcm.01268-22.
• Neurologic Complications of Babesiosis, United States, 2011–2021 - Volume 29, Number 6—June 2023 - Emerging Infectious Diseases journal - CDCLocke S, O’Bryan J, Zubair A, Rethana M, Moffarah A, Krause P, Farhadian S. Neurologic Complications of Babesiosis, United States, 2011–2021 - Volume 29, Number 6—June 2023 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2023, 29: 1127-1135. PMID: 37209667, PMCID: PMC10202888, DOI: 10.3201/eid2906.221890.
• Human Borrelia miyamotoi Infection in North AmericaBurde J, Bloch E, Kelly J, Krause P. Human Borrelia miyamotoi Infection in North America. Pathogens 2023, 12: 553. PMID: 37111439, PMCID: PMC10145171, DOI: 10.3390/pathogens12040553.
• The impact of ABO and RhD blood types on Babesia microti infectionJajosky R, O’Bryan J, Spichler-Moffarah A, Jajosky P, Krause P, Tonnetti L. The impact of ABO and RhD blood types on Babesia microti infection. PLOS Neglected Tropical Diseases 2023, 17: e0011060. PMID: 36696414, PMCID: PMC9901808, DOI: 10.1371/journal.pntd.0011060.
• Animal models of the immunology and pathogenesis of human babesiosisKumar A, Kabra A, Igarashi I, Krause P. Animal models of the immunology and pathogenesis of human babesiosis. Trends In Parasitology 2022, 39: 38-52. PMID: 36470781, DOI: 10.1016/j.pt.2022.11.003.
• Comparing the Epidemiology and Health Burden of Lyme Disease and Babesiosis Hospitalizations in the United StatesBloch E, Zhu X, Krause P, Patel E, Grabowski M, Goel R, Auwaerter P, Tobian A. Comparing the Epidemiology and Health Burden of Lyme Disease and Babesiosis Hospitalizations in the United States. Open Forum Infectious Diseases 2022, 9: ofac597. PMID: 36467296, PMCID: PMC9709699, DOI: 10.1093/ofid/ofac597.
• Human Babesiosis.Waked R, Krause PJ. Human Babesiosis. Infectious Disease Clinics Of North America 2022, 36: 655-670. PMID: 36116841, DOI: 10.1016/j.idc.2022.02.009.
• The utility of a maximum entropy species distribution model for Ixodes scapularis in predicting the public health risk of Lyme disease in Ontario, Canada.Burrows H, Slatculescu AM, Feng CX, Clow KM, Guillot C, Jardine CM, Leighton PA, Krause PJ, Kulkarni MA. The utility of a maximum entropy species distribution model for Ixodes scapularis in predicting the public health risk of Lyme disease in Ontario, Canada. Ticks And Tick-borne Diseases 2022, 13: 101969. PMID: 35640345, DOI: 10.1016/j.ttbdis.2022.101969.
• Cardiac Complications of Human Babesiosis.Spichler-Moffarah A, Ong E, O'Bryan J, Krause PJ. Cardiac Complications of Human Babesiosis. Clinical Infectious Diseases 2022, 76: e1385-e1391. PMID: 35983604, PMCID: PMC10169432, DOI: 10.1093/cid/ciac525.
• Correction: Kumar et al. The Global Emergence of Human Babesiosis. Pathogens 2021, 10, 1447Kumar A, O’Bryan J, Krause PJ. Correction: Kumar et al. The Global Emergence of Human Babesiosis. Pathogens 2021, 10, 1447. Pathogens 2022, 11: 923. PMID: 36015072, PMCID: PMC9415982, DOI: 10.3390/pathogens11080923.
• Borrelia miyamotoi Meningoencephalitis in an Immunocompetent PatientGandhi S, Narasimhan S, Workineh A, Mamula M, Yoon J, Krause PJ, Farhadian SF. Borrelia miyamotoi Meningoencephalitis in an Immunocompetent Patient. Open Forum Infectious Diseases 2022, 9: ofac295. PMID: 35873293, PMCID: PMC9301576, DOI: 10.1093/ofid/ofac295.
• Broad Antimicrobial Resistance in a Case of Relapsing Babesiosis Successfully Treated With Tafenoquine.Rogers R, Krause PJ, Norris AM, Ting MH, Nagami EH, Cilley B, Vannier E. Broad Antimicrobial Resistance in a Case of Relapsing Babesiosis Successfully Treated With Tafenoquine. Clinical Infectious Diseases 2022, 76: 741-744. PMID: 35684960, DOI: 10.1093/cid/ciac473.
• Correction: Kumar et al. The Global Emergence of Human Babesiosis. Pathogens 2021, 10, 1447Kumar A, O’Bryan J, Krause PJ. Correction: Kumar et al. The Global Emergence of Human Babesiosis. Pathogens 2021, 10, 1447. Pathogens 2022, 11: 607. PMID: 35631130, PMCID: PMC9147755, DOI: 10.3390/pathogens11050607.
• Frequency and Geographic Distribution of Borrelia miyamotoi, Borrelia burgdorferi, and Babesia microti Infections in New England Residents.Johnston D, Kelly JR, Ledizet M, Lavoie N, Smith RP, Parsonnet J, Schwab J, Stratidis J, Espich S, Lee G, Maciejewski KR, Deng Y, Majam V, Zheng H, Bonkoungou SN, Stevens J, Kumar S, Krause PJ. Frequency and Geographic Distribution of Borrelia miyamotoi, Borrelia burgdorferi, and Babesia microti Infections in New England Residents. Clinical Infectious Diseases 2022 PMID: 35325084, DOI: 10.1093/cid/ciac107.
• Epidemiology of Hospitalized Patients with Babesiosis, United States, 2010–2016 - Volume 28, Number 2—February 2022 - Emerging Infectious Diseases journal - CDCBloch EM, Day JR, Krause PJ, Kjemtrup A, O’Brien S, Tobian AAR, Goel R. Epidemiology of Hospitalized Patients with Babesiosis, United States, 2010–2016 - Volume 28, Number 2—February 2022 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2022, 28: 354-362. PMID: 35076004, PMCID: PMC8798708, DOI: 10.3201/eid2802.210213.
• The Global Emergence of Human BabesiosisKumar A, O’Bryan J, Krause PJ. The Global Emergence of Human Babesiosis. Pathogens 2021, 10: 1447. PMID: 34832603, PMCID: PMC8623124, DOI: 10.3390/pathogens10111447.
• BabesiosisChen T, Mamoun C, Krause P. Babesiosis. 2021, 1298-1304. DOI: 10.1093/med/9780190888367.003.0200.
• Recurrence of Human Babesiosis Caused by Reinfection - Volume 27, Number 10—October 2021 - Emerging Infectious Diseases journal - CDCHo J, Carey E, Carey DE, Krause PJ. Recurrence of Human Babesiosis Caused by Reinfection - Volume 27, Number 10—October 2021 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2021, 27: 2659-2661. PMID: 34546166, PMCID: PMC8462340, DOI: 10.3201/eid2710.211240.
• Preventing Transfusion-Transmitted BabesiosisBloch EM, Krause PJ, Tonnetti L. Preventing Transfusion-Transmitted Babesiosis. Pathogens 2021, 10: 1176. PMID: 34578209, PMCID: PMC8468711, DOI: 10.3390/pathogens10091176.
• Babesia microti: Pathogen Genomics, Genetic Variability, Immunodominant Antigens, and PathogenesisPuri A, Bajpai S, Meredith S, Aravind L, Krause PJ, Kumar S. Babesia microti: Pathogen Genomics, Genetic Variability, Immunodominant Antigens, and Pathogenesis. Frontiers In Microbiology 2021, 12: 697669. PMID: 34539601, PMCID: PMC8446681, DOI: 10.3389/fmicb.2021.697669.
• Tick hypersensitivity and human tick‐borne diseasesNg YQ, Gupte TP, Krause PJ. Tick hypersensitivity and human tick‐borne diseases. Parasite Immunology 2021, 43: e12819. PMID: 33428244, DOI: 10.1111/pim.12819.
• Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA): 2020 Guideline on Diagnosis and Management of BabesiosisKrause PJ, Auwaerter PG, Bannuru RR, Branda JA, Falck-Ytter YT, Lantos PM, Lavergne V, Meissner HC, Osani MC, Rips JG, Sood SK, Vannier E, Vaysbrot EE, Wormser GP. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA): 2020 Guideline on Diagnosis and Management of Babesiosis. Clinical Infectious Diseases 2021, 72: 185-189. PMID: 33501959, DOI: 10.1093/cid/ciab050.
• Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease.Lantos PM, Rumbaugh J, Bockenstedt LK, Falck-Ytter YT, Aguero-Rosenfeld ME, Auwaerter PG, Baldwin K, Bannuru RR, Belani KK, Bowie WR, Branda JA, Clifford DB, DiMario FJ, Halperin JJ, Krause PJ, Lavergne V, Liang MH, Meissner HC, Nigrovic LE, Nocton JJJ, Osani MC, Pruitt AA, Rips J, Rosenfeld LE, Savoy ML, Sood SK, Steere AC, Strle F, Sundel R, Tsao J, Vaysbrot EE, Wormser GP, Zemel LS. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease. Clinical Infectious Diseases 2021, 72: 1-8. PMID: 33483734, DOI: 10.1093/cid/ciab049.
• 762. Climate Change and the Seroprevalence of Borrelia burgdorferi over 25 Years in Rhode IslandEspich S, Weinberger D, Mancini D, Brancato J, Lee G, Akosa F, Warcup T, Krause P. 762. Climate Change and the Seroprevalence of Borrelia burgdorferi over 25 Years in Rhode Island. Open Forum Infectious Diseases 2020, 7: s427-s427. PMCID: PMC7777808, DOI: 10.1093/ofid/ofaa439.952.
• 644. Borrelia miyamotoi and Borrelia burgdorferi Seroprevalence in New EnglandJohnston D, Kelly J, Ledizet M, Lavoie N, Krause P. 644. Borrelia miyamotoi and Borrelia burgdorferi Seroprevalence in New England. Open Forum Infectious Diseases 2020, 7: s381-s381. PMCID: PMC7777872, DOI: 10.1093/ofid/ofaa439.838.
• Borrelia burgdorferi and Borrelia miyamotoi seroprevalence in California blood donorsBrummitt SI, Kjemtrup AM, Harvey DJ, Petersen JM, Sexton C, Replogle A, Packham AE, Bloch EM, Barbour AG, Krause PJ, Green V, Smith WA. Borrelia burgdorferi and Borrelia miyamotoi seroprevalence in California blood donors. PLOS ONE 2020, 15: e0243950. PMID: 33370341, PMCID: PMC7769429, DOI: 10.1371/journal.pone.0243950.
• Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme DiseaseLantos PM, Rumbaugh J, Bockenstedt LK, Falck-Ytter YT, Aguero-Rosenfeld ME, Auwaerter PG, Baldwin K, Bannuru RR, Belani KK, Bowie WR, Branda JA, Clifford DB, DiMario FJ, Halperin JJ, Krause PJ, Lavergne V, Liang MH, Meissner HC, Nigrovic LE, Nocton J, Osani MC, Pruitt AA, Rips J, Rosenfeld LE, Savoy ML, Sood SK, Steere AC, Strle F, Sundel R, Tsao J, Vaysbrot EE, Wormser GP, Zemel LS. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease. Clinical Infectious Diseases 2020, 72: e1-e48. PMID: 33417672, DOI: 10.1093/cid/ciaa1215.
• Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA): 2020 Guideline on Diagnosis and Management of BabesiosisKrause PJ, Auwaerter PG, Bannuru RR, Branda JA, Falck-Ytter YT, Lantos PM, Lavergne V, Meissner HC, Osani MC, Rips JG, Sood SK, Vannier E, Vaysbrot EE, Wormser GP. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA): 2020 Guideline on Diagnosis and Management of Babesiosis. Clinical Infectious Diseases 2020, 72: e49-e64. PMID: 33252652, DOI: 10.1093/cid/ciaa1216.
• Clinical Practice Guidelines by the Infectious Diseases Society of America, American Academy of Neurology, and American College of Rheumatology: 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme DiseaseLantos PM, Rumbaugh J, Bockenstedt LK, Falck-Ytter YT, Aguero-Rosenfeld ME, Auwaerter PG, Baldwin K, Bannuru RR, Belani KK, Bowie WR, Branda JA, Clifford DB, DiMario FJ, Halperin JJ, Krause PJ, Lavergne V, Liang MH, Meissner HC, Nigrovic LE, Nocton JJJ, Osani MC, Pruitt AA, Rips J, Rosenfeld LE, Savoy ML, Sood SK, Steere AC, Strle F, Sundel R, Tsao J, Vaysbrot EE, Wormser GP, Zemel LS. Clinical Practice Guidelines by the Infectious Diseases Society of America, American Academy of Neurology, and American College of Rheumatology: 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease. Neurology 2020, 96: 262-273. PMID: 33257476, DOI: 10.1212/wnl.0000000000011151.
• Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme DiseaseLantos PM, Rumbaugh J, Bockenstedt LK, Falck‐Ytter Y, Aguero‐Rosenfeld M, Auwaerter PG, Baldwin K, Bannuru RR, Belani KK, Bowie WR, Branda JA, Clifford DB, DiMario FJ, Halperin JJ, Krause PJ, Lavergne V, Liang MH, Meissner H, Nigrovic LE, Nocton J, Osani MC, Pruitt AA, Rips J, Rosenfeld LE, Savoy ML, Sood SK, Steere AC, Strle F, Sundel R, Tsao J, Vaysbrot EE, Wormser GP, Zemel LS. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease. Arthritis Care & Research 2020, 73: 1-9. PMID: 33251700, DOI: 10.1002/acr.24495.
• Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme DiseaseLantos PM, Rumbaugh J, Bockenstedt LK, Falck-Ytter YT, Aguero-Rosenfeld ME, Auwaerter PG, Baldwin K, Bannuru RR, Belani KK, Bowie WR, Branda JA, Clifford DB, DiMario FJ, Halperin JJ, Krause PJ, Lavergne V, Liang MH, Meissner H, Nigrovic LE, Nocton J, Osani MC, Pruitt AA, Rips J, Rosenfeld LE, Savoy ML, Sood SK, Steere AC, Strle F, Sundel R, Tsao J, Vaysbrot EE, Wormser GP, Zemel LS. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease. Arthritis & Rheumatology 2020, 73: 12-20. PMID: 33251716, DOI: 10.1002/art.41562.
• Parasite burden and red blood cell exchange transfusion for babesiosisO'Bryan J, Gokhale A, Hendrickson JE, Krause PJ. Parasite burden and red blood cell exchange transfusion for babesiosis. Journal Of Clinical Apheresis 2020, 36: 127-134. PMID: 33179803, PMCID: PMC9517950, DOI: 10.1002/jca.21853.
• The emergence of human Powassan virus infection in North AmericaCampbell O, Krause PJ. The emergence of human Powassan virus infection in North America. Ticks And Tick-borne Diseases 2020, 11: 101540. PMID: 32993949, DOI: 10.1016/j.ttbdis.2020.101540.
• Antigen Discovery, Bioinformatics and Biological Characterization of Novel Immunodominant Babesia microti AntigensVerma N, Puri A, Essuman E, Skelton R, Anantharaman V, Zheng H, White S, Gunalan K, Takeda K, Bajpai S, Lepore TJ, Krause PJ, Aravind L, Kumar S. Antigen Discovery, Bioinformatics and Biological Characterization of Novel Immunodominant Babesia microti Antigens. Scientific Reports 2020, 10: 9598. PMID: 32533024, PMCID: PMC7293334, DOI: 10.1038/s41598-020-66273-6.
• Management strategies for human babesiosisSmith RP, Hunfeld KP, Krause PJ. Management strategies for human babesiosis. Expert Review Of Anti-infective Therapy 2020, 18: 625-636. PMID: 32268823, DOI: 10.1080/14787210.2020.1752193.
• Clofazimine, a Promising Drug for the Treatment of Babesia microti Infection in Severely Immunocompromised Hosts.Tuvshintulga B, Vannier E, Tayebwa DS, Gantuya S, Sivakumar T, Guswanto A, Krause PJ, Yokoyama N, Igarashi I. Clofazimine, a Promising Drug for the Treatment of Babesia microti Infection in Severely Immunocompromised Hosts. The Journal Of Infectious Diseases 2020, 222: 1027-1036. PMID: 32310272, DOI: 10.1093/infdis/jiaa195.
• 105 BabesiosisVannier E, Krause P. 105 Babesiosis. 2020, 799-802. DOI: 10.1016/b978-0-323-55512-8.00105-8.
• Immunoepidemiology of Immune DysfunctionMeffre E, Krause P, Ruddle N. Immunoepidemiology of Immune Dysfunction. 2019, 127-148. DOI: 10.1007/978-3-030-25553-4_8.
• Introduction to Immunology, Epidemiology, and ImmunoepidemiologyNiccolai L, Ruddle N, Krause P. Introduction to Immunology, Epidemiology, and Immunoepidemiology. 2019, 3-17. DOI: 10.1007/978-3-030-25553-4_1.
• Disorders of the Immune SystemKavathas P, Krause P, Ruddle N. Disorders of the Immune System. 2019, 97-107. DOI: 10.1007/978-3-030-25553-4_6.
• Innate Immunity: Recognition and Effector FunctionsKavathas P, Krause P, Ruddle N. Innate Immunity: Recognition and Effector Functions. 2019, 39-53. DOI: 10.1007/978-3-030-25553-4_3.
• Organization and Cells of the Immune SystemKavathas P, Krause P, Ruddle N. Organization and Cells of the Immune System. 2019, 21-38. DOI: 10.1007/978-3-030-25553-4_2.
• Adaptive Immunity: Antigen Recognition by T and B LymphocytesKavathas P, Krause P, Ruddle N. Adaptive Immunity: Antigen Recognition by T and B Lymphocytes. 2019, 55-74. DOI: 10.1007/978-3-030-25553-4_4.
• Adaptive Immunity: Effector Functions, Regulation, and VaccinationKavathas P, Krause P, Ruddle N. Adaptive Immunity: Effector Functions, Regulation, and Vaccination. 2019, 75-95. DOI: 10.1007/978-3-030-25553-4_5.
• Immunotherapy for Infectious Diseases, Cancer, and AutoimmunityKrause P, Kavathas P, Ruddle N. Immunotherapy for Infectious Diseases, Cancer, and Autoimmunity. 2019, 265-276. DOI: 10.1007/978-3-030-25553-4_16.
• Repeat exchange transfusion for treatment of severe babesiosisRadcliffe C, Krause PJ, Grant M. Repeat exchange transfusion for treatment of severe babesiosis. Transfusion And Apheresis Science 2019, 58: 638-640. PMID: 31526674, DOI: 10.1016/j.transci.2019.07.010.
• Persistence of Babesia microti Infection in HumansBloch EM, Kumar S, Krause PJ. Persistence of Babesia microti Infection in Humans. Pathogens 2019, 8: 102. PMID: 31319461, PMCID: PMC6789900, DOI: 10.3390/pathogens8030102.
• Seroprevalence of Borrelia burgdorferi, B. miyamotoi, and Powassan Virus in Residents Bitten by Ixodes Ticks, Maine, USA - Volume 25, Number 4—April 2019 - Emerging Infectious Diseases journal - CDCSmith RP, Elias SP, Cavanaugh CE, Lubelczyk CB, Lacombe EH, Brancato J, Doyle H, Rand PW, Ebel GD, Krause PJ. Seroprevalence of Borrelia burgdorferi, B. miyamotoi, and Powassan Virus in Residents Bitten by Ixodes Ticks, Maine, USA - Volume 25, Number 4—April 2019 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2019, 25: 804-807. PMID: 30882312, PMCID: PMC6433028, DOI: 10.3201/eid2504.180202.
• Human babesiosisKrause PJ. Human babesiosis. International Journal For Parasitology 2019, 49: 165-174. PMID: 30690090, DOI: 10.1016/j.ijpara.2018.11.007.
• ImmunoepidemiologyKrause PJ, Kavathas P, Ruddle N (eds). Immunoepidemiology. Springer Nature Switzerland, 2019
• BmGPAC, an Antigen Capture Assay for Detection of Active Babesia microti InfectionThekkiniath J, Mootien S, Lawres L, Perrin BA, Gewirtz M, Krause PJ, Williams S, Doggett J, Ledizet M, Mamoun C. BmGPAC, an Antigen Capture Assay for Detection of Active Babesia microti Infection. Journal Of Clinical Microbiology 2018, 56: e00067-18. PMID: 30093394, PMCID: PMC6156295, DOI: 10.1128/jcm.00067-18.
• Response to “Transfusion‐transmitted and community‐acquired babesiosis in New York, 2004 to 2015: a response to why and what to do”Fish D, Krause PJ. Response to “Transfusion‐transmitted and community‐acquired babesiosis in New York, 2004 to 2015: a response to why and what to do”. Transfusion 2018, 58: 1818-1819. PMID: 30133825, DOI: 10.1111/trf.14761.
• Superior real‐time polymerase chain reaction detection of Babesia microti parasites in whole blood utilizing high‐copy BMN antigens as amplification targetsGrabias B, Clement J, Krause PJ, Lepore T, Kumar S. Superior real‐time polymerase chain reaction detection of Babesia microti parasites in whole blood utilizing high‐copy BMN antigens as amplification targets. Transfusion 2018, 58: 1924-1932. PMID: 29664114, DOI: 10.1111/trf.14642.
• Community‐acquired and transfusion‐transmitted babesiosis are increasing: why and what to do?Kumar S, Fish D, Krause PJ. Community‐acquired and transfusion‐transmitted babesiosis are increasing: why and what to do? Transfusion 2018, 58: 617-619. PMID: 29528151, DOI: 10.1111/trf.14518.
• Human Babesiosis Caused by a Babesia crassa–Like Pathogen: A Case SeriesJia N, Zheng YC, Jiang JF, Jiang RR, Jiang BG, Wei R, Liu HB, Huo QB, Sun Y, Chu YL, Fan H, Chang QC, Yao NN, Zhang WH, Wang H, Guo DH, Fu X, Wang YW, Krause PJ, Song JL, Cao WC. Human Babesiosis Caused by a Babesia crassa–Like Pathogen: A Case Series. Clinical Infectious Diseases 2018, 67: 1110-1119. PMID: 29538646, DOI: 10.1093/cid/ciy212.
• Human Borrelia miyamotoi infection in California: Serodiagnosis is complicated by multiple endemic Borrelia speciesKrause PJ, Carroll M, Fedorova N, Brancato J, Dumouchel C, Akosa F, Narasimhan S, Fikrig E, Lane RS. Human Borrelia miyamotoi infection in California: Serodiagnosis is complicated by multiple endemic Borrelia species. PLOS ONE 2018, 13: e0191725. PMID: 29420552, PMCID: PMC5805228, DOI: 10.1371/journal.pone.0191725.
• Case report of the patient source of the Babesia microti R1 reference strain and implications for travelersStahl P, Poinsignon Y, Pouedras P, Ciubotaru V, Berry L, Emu B, Krause PJ, Mamoun C, Cornillot E. Case report of the patient source of the Babesia microti R1 reference strain and implications for travelers. Journal Of Travel Medicine 2017, 25: tax073. PMID: 29394381, PMCID: PMC6927858, DOI: 10.1093/jtm/tax073.
• Human seroprevalence of Borrelia miyamotoi in Manitoba, Canada, in 2011-2014: a cross-sectional studyKadkhoda K, Dumouchel C, Brancato J, Gretchen A, Krause PJ. Human seroprevalence of Borrelia miyamotoi in Manitoba, Canada, in 2011-2014: a cross-sectional study. CMAJ Open 2017, 5: e690-e693. PMID: 28882852, PMCID: PMC5621960, DOI: 10.9778/cmajo.20170070.
• Hard Tick Relapsing Fever Caused by Borrelia miyamotoi in a ChildKrause P, Schwab J, Narasimhan S, Brancato J, Xu G, Rich SM. Hard Tick Relapsing Fever Caused by Borrelia miyamotoi in a Child. The Pediatric Infectious Disease Journal 2016, 35: 1352-1354. PMID: 27626914, PMCID: PMC5106309, DOI: 10.1097/inf.0000000000001330.
• Transfusion-transmitted babesiosisLevin AE, Krause PJ. Transfusion-transmitted babesiosis. Current Opinion In Hematology 2016, 23: 573-580. PMID: 27537475, PMCID: PMC5241272, DOI: 10.1097/moh.0000000000000287.
• Borrelia miyamotoi. In response.Krause PJ, Barbour AG. Borrelia miyamotoi. In response. Annals Of Internal Medicine 2015, 163: 964. PMID: 26666795, DOI: 10.7326/l15-5188.
• Coinfection by Ixodes Tick-Borne Pathogens: Ecological, Epidemiological, and Clinical ConsequencesDiuk-Wasser MA, Vannier E, Krause PJ. Coinfection by Ixodes Tick-Borne Pathogens: Ecological, Epidemiological, and Clinical Consequences. Trends In Parasitology 2015, 32: 30-42. PMID: 26613664, PMCID: PMC4713283, DOI: 10.1016/j.pt.2015.09.008.
• Apheresis for babesiosis: Therapeutic parasite reduction or removal of harmful toxins or both?Saifee NH, Krause PJ, Wu Y. Apheresis for babesiosis: Therapeutic parasite reduction or removal of harmful toxins or both? Journal Of Clinical Apheresis 2015, 31: 454-458. PMID: 26481763, DOI: 10.1002/jca.21429.
• Borrelia miyamotoi: The Newest Infection Brought to Us by Deer Ticks.Krause PJ, Barbour AG. Borrelia miyamotoi: The Newest Infection Brought to Us by Deer Ticks. Annals Of Internal Medicine 2015, 163: 141-2. PMID: 26053967, DOI: 10.7326/m15-1219.
• BabesiosisVannier EG, Diuk-Wasser MA, Mamoun C, Krause PJ. Babesiosis. Infectious Disease Clinics Of North America 2015, 29: 357-370. PMID: 25999229, PMCID: PMC4458703, DOI: 10.1016/j.idc.2015.02.008.
• Human babesiosisChen T, Mamoun C, Krause P. Human babesiosis. 2015, 1295-1301. DOI: 10.1017/cbo9781139855952.226.
• Borrelia miyamotoi infection in nature and in humansKrause PJ, Fish D, Narasimhan S, Barbour AG. Borrelia miyamotoi infection in nature and in humans. Clinical Microbiology And Infection 2015, 21: 631-639. PMID: 25700888, PMCID: PMC4470780, DOI: 10.1016/j.cmi.2015.02.006.
• Babesiosis in China, an emerging threatVannier E, Krause PJ. Babesiosis in China, an emerging threat. The Lancet Infectious Diseases 2014, 15: 137-139. PMID: 25539585, DOI: 10.1016/s1473-3099(14)71062-x.
• Blood transfusion transmission of the tick‐borne relapsing fever spirochete Borrelia miyamotoi in miceKrause PJ, Hendrickson JE, Steeves TK, Fish D. Blood transfusion transmission of the tick‐borne relapsing fever spirochete Borrelia miyamotoi in mice. Transfusion 2014, 55: 593-597. PMID: 25251880, DOI: 10.1111/trf.12879.
• Borrelia miyamotoi sensu lato Seroreactivity and Seroprevalence in the Northeastern United States - Volume 20, Number 7—July 2014 - Emerging Infectious Diseases journal - CDCKrause PJ, Narasimhan S, Wormser GP, Barbour AG, Platonov AE, Brancato J, Lepore T, Dardick K, Mamula M, Rollend L, Steeves TK, Diuk-Wasser M, Usmani-Brown S, Williamson P, Sarksyan DS, Fikrig E, Fish D, . Borrelia miyamotoi sensu lato Seroreactivity and Seroprevalence in the Northeastern United States - Volume 20, Number 7—July 2014 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2014, 20: 1183-1190. PMID: 24960072, PMCID: PMC4073859, DOI: 10.3201/eid2007.131587.
• Monitoring Human Babesiosis Emergence through Vector Surveillance New England, USADiuk-Wasser M, Liu Y, Steeves T, Folsom-O’Keefe C, Dardick K, Lepore T, Bent S, Usmani-Brown S, Telford S, Fish D, Krause P. Monitoring Human Babesiosis Emergence through Vector Surveillance New England, USA. Emerging Infectious Diseases 2014, 20: 225-231. DOI: 10.3201/eid1302/130644.
• Monitoring Human Babesiosis Emergence through Vector Surveillance New England, USA - Volume 20, Number 2—February 2014 - Emerging Infectious Diseases journal - CDCDiuk-Wasser MA, Liu Y, Steeves TK, Folsom-O'Keefe C, Dardick KR, Lepore T, Bent SJ, Usmani-Brown S, Telford SR, Fish D, Krause PJ. Monitoring Human Babesiosis Emergence through Vector Surveillance New England, USA - Volume 20, Number 2—February 2014 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2014, 20: 225-231. PMID: 24447577, PMCID: PMC3901474, DOI: 10.3201/eid2002.130644.
• Lyme Disease and the HeartKrause PJ, Bockenstedt LK. Lyme Disease and the Heart. Circulation 2013, 127: e451-e454. PMID: 23429899, DOI: 10.1161/circulationaha.112.101485.
• Human Borrelia miyamotoi Infection in the United StatesKrause PJ, Narasimhan S, Wormser GP, Rollend L, Fikrig E, Lepore T, Barbour A, Fish D. Human Borrelia miyamotoi Infection in the United States. New England Journal Of Medicine 2013, 368: 291-293. PMID: 23323920, PMCID: PMC3934646, DOI: 10.1056/nejmc1215469.
• 100 BabesiosisVannier E, Krause P. 100 Babesiosis. 2013, 761-763. DOI: 10.1016/b978-1-4160-4390-4.00100-4.
• Chapter 14 Neurological manifestations of human babesiosisUsmani-Brown S, Halperin JJ, Krause PJ. Chapter 14 Neurological manifestations of human babesiosis. 2013, 114: 199-203. PMID: 23829910, DOI: 10.1016/b978-0-444-53490-3.00014-5.
• Transplacental Transmission of Human BabesiosisKrause P, Vannier E. Transplacental Transmission of Human Babesiosis. Infectious Diseases In Clinical Practice 2012, 20: 365-367. DOI: 10.1097/ipc.0b013e3182769089.
• P007 IL-21, B cells and CD4-CD8- T cells are key for resistance to Babesia microti infection in immunosuppressed hostsWilson C, Su J, Silver Z, Laurie S, Telford S, Krause P, Wortis H, Vannier E. P007 IL-21, B cells and CD4-CD8- T cells are key for resistance to Babesia microti infection in immunosuppressed hosts. Cytokine 2012, 59: 521. DOI: 10.1016/j.cyto.2012.06.090.
• Human BabesiosisVannier E, Krause PJ. Human Babesiosis. New England Journal Of Medicine 2012, 366: 2397-2407. PMID: 22716978, DOI: 10.1056/nejmra1202018.
• Cellular basis for clearance of the protozoan parasite Babesia microti in immunocompromised hosts (43.13)Vannier E, Silver Z, Wilson C, Su J, Chiam J, Laurie S, Telford S, Gelfand J, Krause P, Wortis H. Cellular basis for clearance of the protozoan parasite Babesia microti in immunocompromised hosts (43.13). The Journal Of Immunology 2012, 188: 43.13-43.13. DOI: 10.4049/jimmunol.188.supp.43.13.
• Preventing transfusion‐transmitted babesiosis: preliminary experience of the first laboratory‐based blood donor screening programYoung C, Chawla A, Berardi V, Padbury J, Skowron G, Krause PJ, Group T. Preventing transfusion‐transmitted babesiosis: preliminary experience of the first laboratory‐based blood donor screening program. Transfusion 2012, 52: 1523-1529. PMID: 22452654, DOI: 10.1111/j.1537-2995.2012.03612.x.
• Humans Infected with Relapsing Fever Spirochete Borrelia miyamotoi, Russia - Volume 17, Number 10—October 2011 - Emerging Infectious Diseases journal - CDCPlatonov AE, Karan LS, Kolyasnikova NM, Makhneva NA, Toporkova MG, Maleev VV, Fish D, Krause PJ. Humans Infected with Relapsing Fever Spirochete Borrelia miyamotoi, Russia - Volume 17, Number 10—October 2011 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2011, 17: 1816-1823. PMID: 22000350, PMCID: PMC3310649, DOI: 10.3201/eid1710.101474.
• Lyme Borreliosis Coinfections with Anaplasma And BabesiaLantos P, Krause P. Lyme Borreliosis Coinfections with Anaplasma And Babesia. 2011, 149-157. DOI: 10.1002/9780470933961.ch8.
• Long-Term Lyme Disease Antibiotic Therapy Beliefs Among New England ResidentsMacauda MM, Erickson P, Miller J, Mann P, Closter L, Krause PJ. Long-Term Lyme Disease Antibiotic Therapy Beliefs Among New England Residents. Vector-Borne And Zoonotic Diseases 2011, 11: 857-862. PMID: 21417921, DOI: 10.1089/vbz.2010.0116.
• Intravenous Streptomycin for Treatment of Mycobacterium tuberculosis Meningitis in an InfantCourter J, Girotto J, Lobato M, Orcutt D, Burke M, Feder H, Krause P, Cohen‐Abbo A, Salazar J. Intravenous Streptomycin for Treatment of Mycobacterium tuberculosis Meningitis in an Infant. Pharmacotherapy The Journal Of Human Pharmacology And Drug Therapy 2010, 30: 1197-1197. DOI: 10.1592/phco.30.11.1197.
• Emergence of Resistance to Azithromycin-Atovaquone in Immunocompromised Patients with Babesia microti InfectionWormser GP, Prasad A, Neuhaus E, Joshi S, Nowakowski J, Nelson J, Mittleman A, Aguero-Rosenfeld M, Topal J, Krause PJ. Emergence of Resistance to Azithromycin-Atovaquone in Immunocompromised Patients with Babesia microti Infection. Clinical Infectious Diseases 2010, 50: 381-386. PMID: 20047477, DOI: 10.1086/649859.
• Dermatologic Changes Induced by Repeated Ixodes scapularis Bites and Implications for Prevention of Tick-Borne InfectionKrause PJ, Grant-Kels JM, Tahan SR, Dardick KR, Alarcon-Chaidez F, Bouchard K, Visini C, Deriso C, Foppa IM, Wikel S. Dermatologic Changes Induced by Repeated Ixodes scapularis Bites and Implications for Prevention of Tick-Borne Infection. Vector-Borne And Zoonotic Diseases 2009, 9: 603-610. PMID: 19196014, PMCID: PMC2883515, DOI: 10.1089/vbz.2008.0091.
• EDITORIAL: The problem of transfusion‐transmitted babesiosisYoung C, Krause PJ. EDITORIAL: The problem of transfusion‐transmitted babesiosis. Transfusion 2009, 49: 2548-2550. PMID: 20163687, DOI: 10.1111/j.1537-2995.2009.02494.x.
• Update on BabesiosisVannier E, Krause PJ. Update on Babesiosis. Interdisciplinary Perspectives On Infectious Diseases 2009, 2009: 984568. PMID: 19727410, PMCID: PMC2734943, DOI: 10.1155/2009/984568.
• Nosocomial Transmission of Human Granulocytic Anaplasmosis?Krause PJ, Wormser GP. Nosocomial Transmission of Human Granulocytic Anaplasmosis? JAMA 2008, 300: 2308-2309. PMID: 19017920, DOI: 10.1001/jama.2008.665.
• Human BabesiosisVannier E, Gewurz BE, Krause PJ. Human Babesiosis. Infectious Disease Clinics Of North America 2008, 22: 469-488. PMID: 18755385, PMCID: PMC3998201, DOI: 10.1016/j.idc.2008.03.010.
• Human BabesiosisChen T, Krause P. Human Babesiosis. 2008, 1381-1388. DOI: 10.1017/cbo9780511722240.200.
• Persistent and relapsing babesiosis in immunocompromised patients.Krause PJ, Gewurz BE, Hill D, Marty FM, Vannier E, Foppa IM, Furman RR, Neuhaus E, Skowron G, Gupta S, McCalla C, Pesanti EL, Young M, Heiman D, Hsue G, Gelfand JA, Wormser GP, Dickason J, Bia FJ, Hartman B, Telford SR, Christianson D, Dardick K, Coleman M, Girotto JE, Spielman A. Persistent and relapsing babesiosis in immunocompromised patients. Clinical Infectious Diseases 2008, 46: 370-6. PMID: 18181735, DOI: 10.1086/525852.
• Shared features in the pathobiology of babesiosis and malariaKrause PJ, Daily J, Telford SR, Vannier E, Lantos P, Spielman A. Shared features in the pathobiology of babesiosis and malaria. Trends In Parasitology 2007, 23: 605-610. PMID: 17988944, DOI: 10.1016/j.pt.2007.09.005.
• Serum Reactivity against Borrelia burgdorferi OspA in Patients with Rheumatoid Arthritis▿Hsieh YF, Liu HW, Hsu TC, Wei J, Shih CM, Krause PJ, Tsay GJ. Serum Reactivity against Borrelia burgdorferi OspA in Patients with Rheumatoid Arthritis▿. MSphere 2007, 14: 1437-1441. PMID: 17881508, PMCID: PMC2168181, DOI: 10.1128/cvi.00151-07.
• Reply to Pollock, Donta, Wilson, and ArneWormser G, Dattwyler R, Shapiro E, Halperin J, Steere A, Klempner M, Krause P, Bakken J, Strle F, Stanek G, Bockenstedt L, Fish D, Dumler J, Nadelman R. Reply to Pollock, Donta, Wilson, and Arne. Clinical Infectious Diseases 2007, 44: 1137-1139. DOI: 10.1086/513029.
• ATOVAQUONE AND AZITHROMYCIN TREATMENT FOR BABESIOSIS IN AN INFANTRaju M, Salazar JC, Leopold H, Krause PJ. ATOVAQUONE AND AZITHROMYCIN TREATMENT FOR BABESIOSIS IN AN INFANT. The Pediatric Infectious Disease Journal 2007, 26: 181-183. PMID: 17259886, DOI: 10.1097/01.inf.0000250622.11505.8f.
• Reinfection and relapse in early Lyme disease.Krause PJ, Foley DT, Burke GS, Christianson D, Closter L, Spielman A. Reinfection and relapse in early Lyme disease. American Journal Of Tropical Medicine And Hygiene 2006, 75: 1090-4. PMID: 17172372, DOI: 10.4269/ajtmh.2006.75.1090.
• The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of AmericaWormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, Krause PJ, Bakken JS, Strle F, Stanek G, Bockenstedt L, Fish D, Dumler JS, Nadelman RB. The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America. Clinical Infectious Diseases 2006, 43: 1089-1134. PMID: 17029130, DOI: 10.1086/508667.
• Confirmation of Tick Bite by Detection of Antibody to Ixodes Calreticulin Salivary Protein▿Alarcon-Chaidez F, Ryan R, Wikel S, Dardick K, Lawler C, Foppa IM, Tomas P, Cushman A, Hsieh A, Spielman A, Bouchard KR, Dias F, Aslanzadeh J, Krause PJ. Confirmation of Tick Bite by Detection of Antibody to Ixodes Calreticulin Salivary Protein▿. MSphere 2006, 13: 1217-1222. PMID: 16928887, PMCID: PMC1656538, DOI: 10.1128/cvi.00201-06.
• Absence of erythrocyte sequestration in a case of babesiosis in a splenectomized human patientClark IA, Budd AC, Hsue G, Haymore BR, Joyce AJ, Thorner R, Krause PJ. Absence of erythrocyte sequestration in a case of babesiosis in a splenectomized human patient. Malaria Journal 2006, 5: 69. PMID: 16887045, PMCID: PMC1552079, DOI: 10.1186/1475-2875-5-69.
• Hypersensitivity to Ticks and Lyme Disease RiskBurke G, Wikel SK, Spielman A, Telford SR, McKay K, Krause PJ, . Hypersensitivity to Ticks and Lyme Disease Risk. Emerging Infectious Diseases 2005, 11: 36-41. PMID: 15705320, PMCID: PMC3294369, DOI: 10.3201/eid1101.040303.
• Coevolution of Markers of Innate and Adaptive Immunity in Skin and Peripheral Blood of Patients with Erythema MigransSalazar J, Pope C, Sellati T, Feder H, Kiely T, Dardick K, Buckman R, Moore M, Caimano M, Pope J, Krause P, Radolf J. Coevolution of Markers of Innate and Adaptive Immunity in Skin and Peripheral Blood of Patients with Erythema Migrans. The Journal Of Immunology 2003, 171: 4934-4934. DOI: 10.4049/jimmunol.171.9.4934-a.
• Successful Treatment of Human Granulocytic Ehrlichiosis in Children Using RifampinKrause PJ, Corrow CL, Bakken JS. Successful Treatment of Human Granulocytic Ehrlichiosis in Children Using Rifampin. Pediatrics 2003, 112: e252-e253. PMID: 12949322, DOI: 10.1542/peds.112.3.e252.
• Babesiosis in PregnancyFeder HM, Lawlor M, Krause PJ. Babesiosis in Pregnancy. New England Journal Of Medicine 2003, 349: 195-196. PMID: 12853599, DOI: 10.1056/nejm200307103490221.
• Increasing health burden of human babesiosis in endemic sites.Krause PJ, McKay K, Gadbaw J, Christianson D, Closter L, Lepore T, Telford SR, Sikand V, Ryan R, Persing D, Radolf JD, Spielman A. Increasing health burden of human babesiosis in endemic sites. American Journal Of Tropical Medicine And Hygiene 2003, 68: 431-6. PMID: 12875292, DOI: 10.4269/ajtmh.2003.68.431.
• Babesiosis Diagnosis and TreatmentKrause PJ. Babesiosis Diagnosis and Treatment. Vector-Borne And Zoonotic Diseases 2003, 3: 45-51. PMID: 12804380, DOI: 10.1089/153036603765627451.
• BabesiosisLantos P, Krause P. Babesiosis. 2003, 6: 151-164. DOI: 10.1007/978-1-4615-1123-6_9.
• Ehrlichiosis in childrenLantos P, Krause PJ. Ehrlichiosis in children. Seminars In Pediatric Infectious Diseases 2002, 13: 249-256. PMID: 12491230, DOI: 10.1053/spid.2002.127200.
• Disease-Specific Diagnosis of Coinfecting Tickborne Zoonoses: Babesiosis, Human Granulocytic Ehrlichiosis, and Lyme DiseaseKrause PJ, McKay K, Thompson CA, Sikand VK, Lentz R, Lepore T, Closter L, Christianson D, Telford SR, Persing D, Radolf JD, Spielman A. Disease-Specific Diagnosis of Coinfecting Tickborne Zoonoses: Babesiosis, Human Granulocytic Ehrlichiosis, and Lyme Disease. Clinical Infectious Diseases 2002, 34: 1184-1191. PMID: 11941544, DOI: 10.1086/339813.
• BabesiosisKrause PJ. Babesiosis. Medical Clinics Of North America 2002, 86: 361-373. PMID: 11982307, DOI: 10.1016/s0025-7125(03)00092-0.
• Babesiosis: similar to malaria but different.Lantos PM, Krause PJ. Babesiosis: similar to malaria but different. Pediatric Annals 2002, 31: 192-7. PMID: 11905293, DOI: 10.3928/0090-4481-20020301-10.
• Diagnosis of Babesiosis Using an Immunoblot Serologic TestRyan R, Krause P, Radolf J, Freeman K, Spielman A, Lenz R, Levin A. Diagnosis of Babesiosis Using an Immunoblot Serologic Test. MSphere 2001, 8: 1177-1180. PMID: 11687460, PMCID: PMC96246, DOI: 10.1128/cdli.8.6.1177-1180.2001.
• Coinfecting Deer-Associated Zoonoses: Lyme Disease, Babesiosis, and EhrlichiosisGoldstein E, Thompson C, Spielman A, Krause P. Coinfecting Deer-Associated Zoonoses: Lyme Disease, Babesiosis, and Ehrlichiosis. Clinical Infectious Diseases 2001, 33: 676-685. PMID: 11486290, DOI: 10.1086/322681.
• Safety and Immunogenicity of a Recombinant Borrelia burgdorferi Outer Surface Protein A Vaccine Against Lyme Disease in Healthy Children and Adolescents: A Randomized Controlled TrialSikand V, Halsey N, Krause P, Sood S, Geller R, Van Hoecke C, Buscarino C, Parenti D. Safety and Immunogenicity of a Recombinant Borrelia burgdorferi Outer Surface Protein A Vaccine Against Lyme Disease in Healthy Children and Adolescents: A Randomized Controlled Trial. Pediatrics 2001, 108: 123-128. PMID: 11433064, DOI: 10.1542/peds.108.1.123.
• Lactobacillus acidophilus Sepsis in a NeonateThompson C, McCarter Y, Krause P, Herson V. Lactobacillus acidophilus Sepsis in a Neonate. Journal Of Perinatology 2001, 21: 258-260. PMID: 11533845, DOI: 10.1038/sj.jp.7200509.
• HIV in primary care: an educational initiative for child health providersStille C, Berrien V, Krause P. HIV in primary care: an educational initiative for child health providers. Child Care Health And Development 2001, 7: 37-42. DOI: 10.1046/j.1467-0658.2001.00102.x.
• Atovaquone and Azithromycin for the Treatment of BabesiosisKrause P, Lepore T, Sikand V, Gadbaw J, Burke G, Telford S, Brassard P, Pearl D, Azlanzadeh J, Christianson D, McGrath D, Spielman A. Atovaquone and Azithromycin for the Treatment of Babesiosis. New England Journal Of Medicine 2000, 343: 1454-1458. PMID: 11078770, DOI: 10.1056/nejm200011163432004.
• BabesiosisHomer M, Aguilar-Delfin I, Telford S, Krause P, Persing D. Babesiosis. Clinical Microbiology Reviews 2000, 13: 451-469. DOI: 10.1128/cmr.13.3.451.
• BabesiosisKrause P. Babesiosis. Seminars In Pediatric Infectious Diseases 2000, 11: 182-188. DOI: 10.1053/pi.2000.6229.
• BabesiosisHomer M, Aguilar-Delfin I, Telford S, Krause P, Persing D. Babesiosis. Clinical Microbiology Reviews 2000, 13: 451-469. PMID: 10885987, PMCID: PMC88943, DOI: 10.1128/cmr.13.3.451-469.2000.
• Serological Expression Cloning of Novel Immunoreactive Antigens of Babesia microtiLodes M, Houghton R, Bruinsma E, Mohamath R, Reynolds L, Benson D, Krause P, Reed S, Persing D. Serological Expression Cloning of Novel Immunoreactive Antigens of Babesia microti. Infection And Immunity 2000, 68: 2783-2790. PMID: 10768973, PMCID: PMC97488, DOI: 10.1128/iai.68.5.2783-2790.2000.
• Southern extension of the range of human babesiosis in the eastern United States.Eskow E, Krause P, Spielman A, Freeman K, Aslanzadeh J. Southern extension of the range of human babesiosis in the eastern United States. Journal Of Clinical Microbiology 1999, 37: 2051-2. PMID: 10325378, PMCID: PMC85028, DOI: 10.1128/jcm.37.6.2051-2052.1999.
• Persistent Parasitemia after Acute BabesiosisKrause P, Spielman A, Telford S, Sikand V, McKay K, Christianson D, Pollack R, Brassard P, Magera J, Ryan R, Persing D. Persistent Parasitemia after Acute Babesiosis. New England Journal Of Medicine 1998, 339: 160-165. PMID: 9664092, DOI: 10.1056/nejm199807163390304.
• Babesiosis and Babesiosis/Lyme Disease Coinfection in Children and Adults† 910Sharan K, Krause P, Sikand V, Telford S, Baltimore R, Persing D, Christianson D, Brassard P, Devarajan P, Lepore T, Spielman A. Babesiosis and Babesiosis/Lyme Disease Coinfection in Children and Adults† 910. Pediatric Research 1998, 43: 157-157. DOI: 10.1203/00006450-199804001-00931.
• Emerging tick-borne zoonoses: Lyme disease, babesiosis, human granulocytic ehrlichiosisKrause P, Telford S. Emerging tick-borne zoonoses: Lyme disease, babesiosis, human granulocytic ehrlichiosis. Seminars In Pediatric Infectious Diseases 1997, 8: 34-43. DOI: 10.1016/s1045-1870(97)80007-6.
• Concurrent Lyme Disease and Babesiosis: Evidence for Increased Severity and Duration of IllnessKrause P, Telford S, Spielman A, Sikand V, Ryan R, Christianson D, Burke G, Brassard P, Pollack R, Peck J, Persing D. Concurrent Lyme Disease and Babesiosis: Evidence for Increased Severity and Duration of Illness. JAMA 1996, 275: 1657-1660. DOI: 10.1001/jama.1996.03530450047031.
• INCREASED SEVERITY OF LYME DISEASE ILLNESS IN CHILDREN DUE TO CONCURRENT BABESIOSIS. • 1042Krause P, Telford S, Spielman A, Sikand V, Ryan R, Christianson D, Burke G, Persing D. INCREASED SEVERITY OF LYME DISEASE ILLNESS IN CHILDREN DUE TO CONCURRENT BABESIOSIS. • 1042. Pediatric Research 1996, 39: 176-176. DOI: 10.1203/00006450-199604001-01064.
• Infection with a Babesia-Like Organism in Northern CaliforniaPersing D, Herwaldt B, Glaser C, Lane R, Thomford J, Mathiesen D, Krause P, Phillip D, Conrad P. Infection with a Babesia-Like Organism in Northern California. New England Journal Of Medicine 1995, 332: 298-303. PMID: 7816065, DOI: 10.1056/nejm199502023320504.
• ReplyKrause P, Telford S, Ryan R, Conrad P, Wilson M, Thomford J, Spielman A. Reply. The Journal Of Infectious Diseases 1995, 171: 505-506. DOI: 10.1093/infdis/171.2.505.
• Quality standard for assurance of measles immunity among health care workers. The Infectious Diseases Society of America.Krause P, Gross P, Barrett T, Dellinger E, Martone W, McGowan J, Sweet R, Wenzel R. Quality standard for assurance of measles immunity among health care workers. The Infectious Diseases Society of America. Infection Control And Hospital Epidemiology 1994, 15: 193-9. PMID: 8207178, DOI: 10.1086/646889.
• Quality standard for the treatment of bacteremia. The Infectious Diseases Society of America.Gross P, Barrett T, Dellinger E, Krause P, Martone W, McGowan J, Sweet R, Wenzel R. Quality standard for the treatment of bacteremia. The Infectious Diseases Society of America. Infection Control And Hospital Epidemiology 1994, 15: 189-92. PMID: 8207177, DOI: 10.1086/646888.
• Quality standard for antimicrobial prophylaxis in surgical procedures. The Infectious Diseases Society of America.Dellinger E, Gross P, Barrett T, Krause P, Martone W, McGowan J, Sweet R, Wenzel R. Quality standard for antimicrobial prophylaxis in surgical procedures. The Infectious Diseases Society of America. Infection Control And Hospital Epidemiology 1994, 15: 182-8. PMID: 8207176, DOI: 10.1086/646887.
• Consensus development of quality standards.Gross P, Barrett T, Dellinger E, Krause P, Martone W, McGowan J, Sweet R, Wenzel R. Consensus development of quality standards. Infection Control And Hospital Epidemiology 1994, 15: 180-1. PMID: 8207175, DOI: 10.1086/646886.
• Quality Standard for Assurance of Measles Immunity Among Health Care WorkersKrause P, Gross P, Barrett T, Dellinger E, Martone W, McGowan J, Sweet R, Wenzel R. Quality Standard for Assurance of Measles Immunity Among Health Care Workers. Infection Control And Hospital Epidemiology 1994, 15: 193-199. DOI: 10.2307/30145560.
• Quality Standard for the Treatment of BacteremiaGross P, Barrett T, Dellinger E, Krause P, Martone W, McGowan J, Sweet R, Wenzel R. Quality Standard for the Treatment of Bacteremia. Infection Control And Hospital Epidemiology 1994, 15: 189-192. DOI: 10.2307/30145559.
• Quality Standard for Antimicrobial Prophylaxis in Surgical ProceduresDellinger E, Gross P, Barrett T, Krause P, Martone W, McGowan J, Sweet R, Wenzel R. Quality Standard for Antimicrobial Prophylaxis in Surgical Procedures. Infection Control And Hospital Epidemiology 1994, 15: 182-188. DOI: 10.2307/30145558.
• Consensus Development of Quality StandardsGross P, Barrett T, Dellinger E, Krause P, Martone W, McGowan J, Sweet R, Wenzel R. Consensus Development of Quality Standards. Infection Control And Hospital Epidemiology 1994, 15: 180-181. DOI: 10.2307/30145557.
• Quality Standard for Antimicrobial Prophylaxis in Surgical ProceduresDellinger E, Gross P, Barrett T, Krause P, Martone W, McGowan J, Sweet R, Wenzel R. Quality Standard for Antimicrobial Prophylaxis in Surgical Procedures. Clinical Infectious Diseases 1994, 18: 422-427. PMID: 8011827, DOI: 10.1093/clinids/18.3.422.
• Characterization of a direct effect of phorbol myristate acetate on human neutrophil cell membrane using 31D8 monoclonal antibodyWoronick C, Maderazo E, Anthony M, Krause P, Sha'afi R. Characterization of a direct effect of phorbol myristate acetate on human neutrophil cell membrane using 31D8 monoclonal antibody. Journal Of Leukocyte Biology 1992, 51: 289-295. PMID: 1541911, DOI: 10.1002/jlb.51.3.289.
• Cytomegalovirus antibody detection in blood donors and mothers of very low birth weight neonates by using three serologic methodsEisenfeld L, McLaughlin J, Mayo D, Klevjer-Anderson P, Silver H, Krause P, Anderson J, Herson V, Savidakis J, Lazar A, Rosenkrantz T, DeSilva H, Ryan R, group C, LeConche D, Donovan T, Ellis K, Buchanan D, Raye J, Pisciotto P, Rowe D, Knox I, Philipps A, Whiteley D, Apollonio J, Schick J, Conlon M. Cytomegalovirus antibody detection in blood donors and mothers of very low birth weight neonates by using three serologic methods. Diagnostic Microbiology And Infectious Disease 1992, 15: 125-128. PMID: 1315230, DOI: 10.1016/0732-8893(92)90035-r.
• Modulation of Neonatal Neutrophil Function by PentoxifyllineKrause P, Maderazo E, Contrino J, Eisenfeld L, Herson V, Greca N, Bannon P, Kreutzer D. Modulation of Neonatal Neutrophil Function by Pentoxifylline. Pediatric Research 1991, 29: 123-127. PMID: 2014147, DOI: 10.1203/00006450-199102000-00002.
• Longitudinal study of neutrophil adherence and motilityEisenfeld L, Krause P, Herson V, Savidakis J, Bannon P, Maderazo E, Woronick C, Giuliano C, Banco L. Longitudinal study of neutrophil adherence and motility. The Journal Of Pediatrics 1990, 117: 926-929. PMID: 2246695, DOI: 10.1016/s0022-3476(05)80139-8.
• The Role of Cellular Maturation in Neutrophil HeterogeneityKrause P, Todd M, Hancock W, Pastuszak W, Maderazo E, Hild D, Kosciol C. The Role of Cellular Maturation in Neutrophil Heterogeneity. Blood 1990, 76: 1639-1646. DOI: 10.1182/blood.v76.8.1639.1639.
• The role of cellular maturation in neutrophil heterogeneity.Krause P, Todd M, Hancock W, Pastuszak W, Maderazo E, Hild D, Kosciol C. The role of cellular maturation in neutrophil heterogeneity. Blood 1990, 76: 1639-46. PMID: 2207334, DOI: 10.1182/blood.v76.8.1639.bloodjournal7681639.
• Effects of Intravenous Fat Infusion on Neonatal Neutrophil and Platelet FunctionHerson V, Block C, Eisenfeld L, Maderazo E, Krause P. Effects of Intravenous Fat Infusion on Neonatal Neutrophil and Platelet Function. Journal Of Parenteral And Enteral Nutrition 1989, 13: 620-622. PMID: 2515309, DOI: 10.1177/0148607189013006620.
• Enhancement of neutrophil function for treatment of neonatal infectionsKRAUSE P, HERSON V, EISENFELD L, JOHNSON G. Enhancement of neutrophil function for treatment of neonatal infections. The Pediatric Infectious Disease Journal 1989, 8: 382-389. PMID: 2664694, DOI: 10.1097/00006454-198906000-00011.
• Characterization of Nonmotile Neutrophil Subpopulations in Neonates and AdultsKrause P, Kreutzer D, Eisenfeld L, Herson V, Weisman S, Bannon P, Greca N. Characterization of Nonmotile Neutrophil Subpopulations in Neonates and Adults. Pediatric Research 1989, 25: 519-524. PMID: 2717268, DOI: 10.1203/00006450-198905000-00019.
• The Effect of Betamethasone on Neonatal Neutrophil ChemotaxisFuenfer M, Herson V, Raye J, Woronick C, Eisenfeld L, Ingardia C, Block C, Krause P. The Effect of Betamethasone on Neonatal Neutrophil Chemotaxis. Pediatric Research 1987, 22: 150-153. PMID: 3658539, DOI: 10.1203/00006450-198708000-00009.
• Host defense during pregnancy: Neutrophil chemotaxis and adherenceKrause P, Ingardia C, Pontius L, Malech H, LoBello T, Maderazo E. Host defense during pregnancy: Neutrophil chemotaxis and adherence. American Journal Of Obstetrics And Gynecology 1987, 157: 274-280. PMID: 3618673, DOI: 10.1016/s0002-9378(87)80150-3.
• HETEROGENEITY OF NEUTROPHIL (PMN) FUNCTION AND MONOCLONAL ANTIBODY (MAb) BINDING IN NEONATES AND ADULTSKrause P, Bannon P, Eisenfeld L, Herson V, Kosciol K, Davidson K. HETEROGENEITY OF NEUTROPHIL (PMN) FUNCTION AND MONOCLONAL ANTIBODY (MAb) BINDING IN NEONATES AND ADULTS. Pediatric Research 1987, 21: 328-328. DOI: 10.1203/00006450-198704010-00964.
• Polymorphonuclear Leukocyte Heterogeneity in Neonates and AdultsKrause P, Malech H, Kristie J, Kosciol C, Herson V, Eisenfeld L, Pastuszak W, Kraus A, Seligmann B. Polymorphonuclear Leukocyte Heterogeneity in Neonates and Adults. Blood 1986, 68: 200-204. DOI: 10.1182/blood.v68.1.200.200.
• Polymorphonuclear Leukocyte Adherence and Chemotaxis in Stressed and Healthy NeonatesKrause P, Herson V, Boutin-Lebowitz J, Eisenfeld L, Block C, LoBello T, Maderazo E. Polymorphonuclear Leukocyte Adherence and Chemotaxis in Stressed and Healthy Neonates. Pediatric Research 1986, 20: 296-300. PMID: 3703618, DOI: 10.1203/00006450-198604000-00004.
• Successful management of Mycobacterium intracellulare pneumonia in a childKRAUSE P, HIGHT D, SCHWARTZ A, MUELLER R, KLEINMAN L, LEOPOLD H, ISEMAN M. Successful management of Mycobacterium intracellulare pneumonia in a child. The Pediatric Infectious Disease Journal 1986, 5: 269-271. PMID: 3952014, DOI: 10.1097/00006454-198603000-00022.
• 1094 THE EFFECT OF BETAMETHASONE ON THE CHEMOTACTIC RESPONSE OF NEONATAL NEUTROPHILSFuenfer M, Ingardia C, Raye J, Block C, Krause P. 1094 THE EFFECT OF BETAMETHASONE ON THE CHEMOTACTIC RESPONSE OF NEONATAL NEUTROPHILS. Pediatric Research 1985, 19: 293-293. DOI: 10.1203/00006450-198504000-01124.
• 1001 NEUTROPHIL HETEROGENEITY IN NEONATES AND ADULTSKrause P, Kosciol C, Pontius L, Malech H, Rave J. 1001 NEUTROPHIL HETEROGENEITY IN NEONATES AND ADULTS. Pediatric Research 1985, 19: 277-277. DOI: 10.1203/00006450-198504000-01031.
• 1411 INDOMETHACIN (I) ASSOCIATED SEPSIS IN VERY LOW BIRTH WEIGHT INFANTSHerson V, Krause P, Eisenfeld L, Maderazo E, Raye J. 1411 INDOMETHACIN (I) ASSOCIATED SEPSIS IN VERY LOW BIRTH WEIGHT INFANTS. Pediatric Research 1985, 19: 346-346. DOI: 10.1203/00006450-198504000-01435.
• ReplyKrause P, Hyams J. Reply. The Journal Of Pediatrics 1985, 106: 344. DOI: 10.1016/s0022-3476(85)80323-1.
• Occurrence of Clostridium difficile toxin-associated gastroenteritis following antibiotic therapy for otitis media in young childrenHYAMS J, FEDER H, KRAUSE P, FRICK J, MCLAUGHLIN J, FURTH T, HINE P. Occurrence of Clostridium difficile toxin-associated gastroenteritis following antibiotic therapy for otitis media in young children. The Pediatric Infectious Disease Journal 1984, 3: 433-436. PMID: 6333674, DOI: 10.1097/00006454-198409000-00009.
• ReplyKrause P, Hyams J. Reply. The Journal Of Pediatrics 1984, 104: 325. DOI: 10.1016/s0022-3476(84)81036-7.
• Fatal Epstein-Barr virus disease in a Laotian refugeeKRAUSE P, HYAMS J, ANDIMAN W, ASCUITTO R, LUDWIG M, BECHTOLD T, HARADA S, SAEMUNDSEN A, PURTILO D. Fatal Epstein-Barr virus disease in a Laotian refugee. The Pediatric Infectious Disease Journal 1984, 3: 50-53. PMID: 6322142, DOI: 10.1097/00006454-198401000-00012.
• Unreliability of Rotazyme ELISA test in neonatesKrause P, Hyams J, Middleton P, Herson V, Flores J. Unreliability of Rotazyme ELISA test in neonates. The Journal Of Pediatrics 1983, 103: 259-262. PMID: 6308197, DOI: 10.1016/s0022-3476(83)80361-8.
• Lymph node biopsy for early diagnosis in Kawasaki diseaseGiesker D, Krause P, Pastuszak W, Hine P, Forouhar F. Lymph node biopsy for early diagnosis in Kawasaki disease. The American Journal Of Surgical Pathology 1982, 6: 493-502. PMID: 7149090, DOI: 10.1097/00000478-198209000-00001.
• Abnormalities of neutrophil adherence in newborns.Krause P, Maderazo E, Scroggs M. Abnormalities of neutrophil adherence in newborns. Pediatrics 1982, 69: 184-7. PMID: 7058092, DOI: 10.1542/peds.69.2.184.
• Lactose malabsorption following rotavirus infection in young childrenHyams J, Krause P, Gleason P. Lactose malabsorption following rotavirus infection in young children. The Journal Of Pediatrics 1981, 99: 916-918. PMID: 6273520, DOI: 10.1016/s0022-3476(81)80020-0.